Tumor flare-like response: A novel imaging phenomenon with predictive significance in triple negative breast cancer patients undergoing neoadjuvant immuno-chemotherapy.

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://www.ncbi.nlm.nih.gov/pubmed/42214154

Bing Jie Zheng; Cheng Zheng Wang; Chun Miao Xu; Cong Yu Li; Ho-Young Song; Jia Yu Wang; Jin Rong Qu; Ming Ge Liu; Quan Li Gao; Ren Zhi Zhang; Wen Juan Xu; Xia Yu Yue; Xiang Li; Xue Jun Chen; Ya Fei Chen; Yu Chen; Zhen Zhen Liu

May 30, 2026